Tarsons Products Limited (TARSONS) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Tarsons Products Limited stock ₹59.22, price ₹310, that is 80.9% below the price, quality 40 out of 100. Rating: strongly overvalued. Calculated from audited financials with 13 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Tarsons Products Limited
TARSONS · NSEFar too expensive (fair value 81% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.
How to read this chart
60‑month range ₹166.46 – ₹867.38 · fair‑value band ₹44.41 – ₹73.84 · the ₹310.30 price screens above the ₹59.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.
Every Wednesday you see whether Tarsons Products is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally.
Show moreShow less
The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusables, magnetic stirrer bar, pp storage plates, sampling aids, vials and tubes, and volumetric reusables.
It also provides general lab ware products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.
Stock analysis
Tarsons Products Limited (TARSONS) currently trades at ₹310.30, while our model-based Fair Value estimate is ₹59.22, 81% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹150.21 per share, and 1 of the 12 models we run sit above the ₹310.30 price.
Bear case: the Dividend Discount group reads lowest at ₹20.00, and 11 of the 12 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹44.41 (bear) to ₹73.84 (bull), the price of ₹310.30 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Tarsons Products Limited reported revenue of ₹4.2B in FY2026 versus ₹3.0B in FY2022, a compound +8.9%/yr. Reported net income was ₹143M in FY2026, compounding −38.6%/yr from FY2022.
Key figures
Market cap ₹16.5B (≈ $176M) Micro · P/E ratio 147.1 · P/S ratio 3.74 · EPS (TTM) ₹2.11 · Dividend yield 0.7% · Net margin 2.5% · Return on equity 2.3% · Return on assets (EBIT) 14.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 25 out of 100 (low confidence).
What moves the price
The share trades about 14% below its 52-week high and 86% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −81%, TARSONS screens richer than that median.
Fair Value models
All 13 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
TARSONS screens overvalued: fair value 81% below the price. Compare with Intuitive Surgical, Inc →
Compare Tarsons Products Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 199 stocks
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- P/S ratio by industry
- EBIT margin by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Solventum Corporation SOLV | $88.65 | $131.27 | +48% | vs TARSONS |
| EssilorLuxottica Société anonyme EL | €184.50 | €196.22 | +6% | vs TARSONS |
| Intuitive Surgical, Inc ISRG | $437.75 | $353.90 | −19% | vs TARSONS |
| Medline Inc MDLN | $39.17 | $28.59 | −27% | vs TARSONS |
| Alcon Inc ALC | CHF 62.14 | CHF 35.08 | −44% | vs TARSONS |
| Becton, Dickinson and Company BDX | $216.47 | $97.80 | −55% | vs TARSONS |
| Straumann Holding STMN | CHF 108.75 | CHF 45.50 | −58% | vs TARSONS |
| West Pharmaceutical Services, Inc WST | $417.80 | $139.22 | −67% | vs TARSONS |
| Sartorius Stedim Biotech S.A DIM | €225.20 | €54.82 | −76% | vs TARSONS |
| Sartorius Aktiengesellschaft SRT | €226.50 | €46.44 | −80% | vs TARSONS |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Tarsons Products Limited (TARSONS) overvalued or undervalued?
What is the fair value of TARSONS?
What is the quality score of TARSONS?
What is the price target for Tarsons Products Limited (TARSONS)?
What is the Tarsons Products Limited stock forecast for 2026?
What is the revenue of Tarsons Products Limited (TARSONS)?
Does Tarsons Products Limited pay a dividend?
How much is the dividend of Tarsons Products Limited (TARSONS)?
What is the intrinsic value of Tarsons Products Limited (TARSONS)?
Is Tarsons Products Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of TARSONS?
How much is Tarsons Products Limited worth?
What do the bullish and bearish scenarios say about TARSONS?
What is the P/E ratio of TARSONS?
How solid is the balance sheet of Tarsons Products Limited (TARSONS)?
How far is TARSONS from its 52-week high?
Which stocks are comparable to Tarsons Products Limited?
Is Tarsons Products Limited stock attractive at the current price?
How is the fair value of TARSONS calculated?
Is it still worth investing in stocks now?
What is the share price of Tarsons Products Limited (TARSONS)?
What should I pay attention to with Tarsons Products Limited right now?
Key figures of Tarsons Products Limited
How large is the market capitalisation of Tarsons Products Limited (TARSONS)?
What is the P/S ratio of Tarsons Products Limited (TARSONS)?
What are the earnings per share of Tarsons Products Limited (TARSONS)?
What is the dividend yield of Tarsons Products Limited (TARSONS)?
What is the net margin of Tarsons Products Limited (TARSONS)?
What is the return on equity of Tarsons Products Limited (TARSONS)?
What is the EBIT return on assets of Tarsons Products Limited (TARSONS)?
What is the operating margin of Tarsons Products Limited (TARSONS)?
How fast is revenue growing at Tarsons Products Limited (TARSONS)?
How fast are earnings growing at Tarsons Products Limited (TARSONS)?
How much free cash flow does Tarsons Products Limited (TARSONS) generate?
How much net debt does Tarsons Products Limited (TARSONS) carry?
Watch Tarsons Products Limited in the live analysis
One click puts Tarsons Products Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.